CC
MRTX

Clearline Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Clearline Capital’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-51,275
Closed -$3.01M – 141
2023
Q4 		$3.01M Hold
51,275
– – 0.18% 62
2023
Q3 		$2.23M Sell
51,275
-5,066
-9% -$221K 0.19% 82
2023
Q2 		$2.04M Buy
+56,341
New +$2.04M 0.12% 72